Mutant DMPK 3′-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD
Open Access
- 11 November 2002
- journal article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 159 (3) , 419-429
- https://doi.org/10.1083/jcb.200206020
Abstract
Myotonic dystrophy (DM) is caused by two similar noncoding repeat expansion mutations (DM1 and DM2). It is thought that both mutations produce pathogenic RNA molecules that accumulate in nuclear foci. The DM1 mutation is a CTG expansion in the 3′ untranslated region (3′-UTR) of dystrophia myotonica protein kinase (DMPK). In a cell culture model, mutant transcripts containing a (CUG)200 DMPK 3′-UTR disrupt C2C12 myoblast differentiation; a phenotype similar to what is observed in myoblast cultures derived from DM1 patient muscle. Here, we have used our cell culture model to investigate how the mutant 3′-UTR RNA disrupts differentiation. We show that MyoD protein levels are compromised in cells that express mutant DMPK 3′-UTR transcripts. MyoD, a transcription factor required for the differentiation of myoblasts during muscle regeneration, activates differentiation-specific genes by binding E-boxes. MyoD levels are significantly reduced in myoblasts expressing the mutant 3′-UTR RNA within the first 6 h under differentiation conditions. This reduction correlates with blunted E-box–mediated gene expression at time points that are critical for initiating differentiation. Importantly, restoring MyoD levels rescues the differentiation defect. We conclude that mutant DMPK 3′-UTR transcripts disrupt myoblast differentiation by reducing MyoD levels below a threshold required to activate the differentiation program.Keywords
This publication has 52 references indexed in Scilit:
- Myotonic Dystrophy in Transgenic Mice Expressing an Expanded CUG RepeatScience, 2000
- Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophyThe EMBO Journal, 2000
- Myotonic DystrophyMolecular Cell, 2000
- Bone Morphogenetic Protein-2 Inhibits Terminal Differentiation of Myogenic Cells by Suppressing the Transcriptional Activity of MyoD and MyogeninExperimental Cell Research, 1997
- Myogenin gene disruption results in perinatal lethality because of severe muscle defectNature, 1993
- Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin geneNature, 1993
- Deficiency in Rhabdomyosarcomas of a Factor Required for MyoD Activity and MyogenesisScience, 1993
- ErratumCell, 1992
- MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancerCell, 1989
- Cytoplasmic activation of human nuclear genes in stable heterocaryonsCell, 1983